Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patientsAravintho Natarajan, Venkatesh Rangarajan, Sneha Shah et al.|World Journal of Nuclear Medicine|2019Cited by 16
Bone metastases in prostate cancer – Gallium-68–labeled prostate-specific membrane antigen or Fluorine 18 sodium fluoride PET/computed tomography – the better tracer?Archi Agrawal, Venkatesh Rangarajan, Aravintho Natarajan et al.|Nuclear Medicine Communications|2022Cited by 11
Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRIAjay Sasidharan, Palak Popat, Somesh Singh et al.|Nuclear Medicine Communications|2020Cited by 4